HCA
PFE icon

Harbour Capital Advisors’s Pfizer PFE Stock Holding History

Harbour Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,824
Closed -$253K – 230
2022
Q2 		$253K Hold
4,824
– – 0.08% 187
2022
Q1 		$250K Hold
4,824
– – 0.07% 199
2021
Q4 		$285K Hold
4,824
– – 0.07% 199
2021
Q3 		$207K Buy
+4,824
New +$214K 0.05% 231
2020
Q2 		– Sell
-6,493
Closed -$201K – 201
2020
Q1 		$201K Sell
6,493
-527
-8% -$18K 0.1% 167
2019
Q4 		$261K Sell
7,020
-105
-1% -$3.74K 0.1% 181
2019
Q3 		$243K Hold
7,125
– – 0.1% 181
2019
Q2 		$293K Sell
7,125
-582
-8% -$23.1K 0.13% 165
2019
Q1 		$311K Sell
7,707
-1,815
-19% -$72.7K 0.14% 159
2018
Q4 		$394K Sell
9,522
-1,031
-10% -$42.8K 0.2% 130
2018
Q3 		$441K Sell
10,553
-479
-4% -$18.4K 0.18% 112
2018
Q2 		$380K Hold
11,032
– – 0.16% 145
2018
Q1 		$371K Sell
11,032
-822
-7% -$28.3K 0.16% 158
2017
Q4 		$407K Buy
11,854
+1,601
+16% +$54.6K 0.17% 148
2017
Q3 		$347K Sell
10,253
-2,872
-22% -$92.3K 0.15% 171
2017
Q2 		$418K Sell
13,125
-844
-6% -$26.6K 0.21% 142
2017
Q1 		$453K Buy
+13,969
New +$440K 0.21% 132
2016
Q3 		– Sell
-14,390
Closed -$481K – 269
2016
Q2 		$481K Sell
14,390
-11,542
-45% -$368K 0.27% 125
2016
Q1 		$729K Sell
25,932
-4,110
-14% -$117K 0.41% 81
2015
Q4 		$920K Buy
+30,042
New +$945K 0.5% 62
2015
Q3 		– Sell
-8,699
Closed -$277K – 213
2015
Q2 		$277K Buy
+8,699
New +$284K 0.17% 162
2014
Q1 		– Sell
-8,234
Closed -$239K – 194
2013
Q4 		$239K Buy
8,234
+439
+6% +$12.8K 0.21% 152
2013
Q3 		$212K Buy
7,795
+100
+1% +$2.72K 0.23% 155
2013
Q2 		$205K Buy
+7,695
New +$213K 0.26% 146

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Harbour Capital Advisors's PFE Position: Q3 2022 in Review

Harbour Capital Advisors sold out of Pfizer (PFE) in Q3 2022, closing a stake of 4,824 shares — an estimated $253K sold.

Harbour Capital Advisors first reported a position in PFE in Q2 2013 and held it in 24 quarters. The position peaked at $920K in Q4 2015. 3,088 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • Harbour Capital Advisors reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
  • Harbour Capital Advisors sold 4,824 Pfizer shares in Q3 2022, an estimated $253K.
  • Harbour Capital Advisors first reported a position in Pfizer in Q2 2013 and held it in 24 quarters.
  • Harbour Capital Advisors's Pfizer position peaked at $920K in Q4 2015.
  • 3,088 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Harbour Capital Advisors's 13F filing for Q3 2022, filed 19 Oct 2022.